Romanian Health Spending, Drug Imports Slammed

4 May 1997

Romanian Health Minister Stefan Dragulescu says the 2.7% of 1997 GrossDomestic Product allocated for health care is insufficient; at least 4% is needed to maintain services, reports Mediafax. Finance Minister Mircea Ciumara agrees but says no extra resources are available, although he adds that shortages could be overcome partly if existing funding was managed efficiently.

Mr Ciumara has also criticized "the white mafia of medicine importers," which he says is damaging the Romanian drugs and medical products industry. Medicines are being imported even though domestic plants are manufacturing the same products, which are sold at higher prices, he said, noting that this situation has resulted from the imports being exempt from customs duties.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight